Epidemiology, prevention, and treatment of new-onset atrial fibrillation in critically ill: a systematic review

Table 3 Incidences of new-onset atrial fibrillation and severity scores of the study population

Author, year [ref]	Setting patients	Incidence of AF (no.)	Severity score	Mean score ^a
Bender JS, 1996 [49]	Surgical ICU	6.8% (14/206)	NA	NA
Seguin P, 2004 [50]	Surgical ICU	5.3% (24/453)	SAPS II	45 vs. 31 (p = 0.0001)
Seguin P, 2006 [51]	Surgical ICU (trauma)	5.5% (16/293)	SAPS II	47 vs. 31 (p < 0.001)
Arora S, 2007 [52]	Mixed ICU	29.5% (18/61)	APACHE II	25.4 vs. 20.0 (p = 0.005)
Arora S, 2007 [52]	Mixed ICU	29.5% (18/61)	SAPS II	47.8 vs. 37.1 (p = 0.001)
Christian SA, 2008 [26]	Mixed ICU (sepsis)	5.9% (16/272)	APACHE II predicted survival	49% vs. 55% (p = 0.36)
Meierhenrich R, 2010 [53]	Surgical ICU	All patients 7.8% (49/629)	SAPS II	NA
Meierhenrich R, 2010 [53]	Surgical ICU	Septic shock 46.0% (23/50)	SAPS II	31 vs. 30^b (p = 0.12)
Walkey AJ, 2011 [54]	Acute care hospitals (severe sepsis)	5.9% (2,896/49,082)	Number of organ failures	3.11 vs. 3.08^b (p = 0.42)
Kanji S, 2012 [55]	Three mixed ICUs	4.5% (139/3,081)	APACHE II	22.6^c
Tongyaoo S, 2013 [56]	Medical ICU	13.8% (34/247)	APACHE II	24.4 vs. 17.0^d (p < 0.001)
Makrygiannis SS, 2014 [57]	Mixed ICU	15.0% (20/133)	APACHE II	17.9 vs. 15.7 (p = 0.16)

AF atrial fibrillation, APACHE II Acute Physiology and Chronic Health Evaluation II, SAPS II Simplified Acute Physiology Score II, NA not available.
^aAtrial fibrillation vs. no atrial fibrillation.
^bMedian.
^cNo information for APACHE II in no new-onset AF patients provided.
^dAll types of supraventricular tachyarrhythmia included.

ISSN: 2052-0492